Stay updated on AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration
Sign up to get notified when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.

Latest updates to the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page
- Check5 days agoChange DetectedThe Publications section adds the AREDS2 JAMA 2013 publication entry with its erratum and removes the earlier citation, and the study revision is updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page now shows Revision: v3.4.2, replacing the previous revision. The government funding status notice and the Revision: v3.4.1 notice were removed.SummaryDifference0.2%

- Check77 days agoChange DetectedAdded a system-wide notice about a lapse in government funding and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check84 days agoChange DetectedAdded a glossary toggle, updated the label to 'Last Update Submitted that Met QC Criteria', corrected capitalization to 'No FEAR Act Data', and introduced 'Revision: v3.4.0'.SummaryDifference0.1%

Stay in the know with updates to AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration
Enter your email address, and we'll notify you when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.